Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-03-07

Clinical Trial Update: Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating epidural dexamethasone for labor analgesia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone (epidural) (dexamethasone)

Snippet

Sponsor: Centre Hospitalier Universitaire de la Réunion | Conditions: Obstetric Pain, Other Complications of Obstetric Anesthesia - Delivered | Phase 3 | Status: WITHDRAWN